Slaoui resigned from the board of biotech company Moderna on Friday, one of the companies with the most advanced effort to create a vaccine in ...
News
- Trump promises hundreds of millions of coronavirus vaccines by January, but scientists doubt it
- Other news to note for May 15, 2020
Bluegrass Vascular Technologies Inc., of San Antonio, Texas, reported that ... Piscataway, N.J.-based Genscript Biotech Corp. has joined forces with ...
- Initial public offerings scheduled to debut next week
Business: Swiss phase 2 biotech developing next generation drugs for cancer. NOVUS Capital Corp - Indianapolis, Ind. - 10 million shares, priced at $10 ...
- Correction: Earns-Salarius story
The biotech drug developer posted revenue of $1.1 million in the period. In the final minutes of trading on Thursday, the company's shares hit 84 cents. A ...
- Snohomish County health officials probe positive blood tests
... Dr. Jared Roach, a senior research scientist at the Institute for Systems Biology, a Seattle-based biomedical research firm, told the newspaper.